TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
PTC Therapeutics Sweden AB
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
36,881
|
29,959
|
28,789 |
| Financial expenses |
11
|
0
|
0 |
| Earnings before taxes |
1,960
|
1,705
|
1,630 |
| EBITDA |
1,971
|
1,697
|
1,630 |
| Total assets |
17,137
|
14,174
|
11,547 |
| Current assets |
17,137
|
14,174
|
11,509 |
| Current liabilities |
9,313
|
7,847
|
6,550 |
| Equity capital |
7,824
|
6,327
|
4,997 |
| - share capital |
55
|
55
|
55 |
| Employees (average) |
9
|
8
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
45.7%
|
44.6%
|
43.3% |
| Turnover per employee |
4,098
|
3,745
|
4,113 |
| Profit as a percentage of turnover |
5.3%
|
5.7%
|
5.7% |
| Return on assets (ROA) |
11.5%
|
12.0%
|
14.1% |
| Current ratio |
184.0%
|
180.6%
|
175.7% |
| Return on equity (ROE) |
25.1%
|
26.9%
|
32.6% |
| Change turnover |
6,922
|
1,170
|
4,445 |
| Change turnover % |
23%
|
4%
|
18% |
| Chg. No. of employees |
1
|
1
|
0 |
| Chg. No. of employees % |
13%
|
14%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.